These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 9572160

  • 1. Intestinal handling of mercury in the rat: implications of intestinal secretion of inorganic mercury following biliary ligation or cannulation.
    Zalups RK.
    J Toxicol Environ Health A; 1998 Apr 24; 53(8):615-36. PubMed ID: 9572160
    [Abstract] [Full Text] [Related]

  • 2. Diversion or prevention of biliary outflow from the liver diminishes the renal uptake of injected inorganic mercury.
    Zalups RK, Barfuss DW.
    Drug Metab Dispos; 1996 Apr 24; 24(4):480-6. PubMed ID: 8801064
    [Abstract] [Full Text] [Related]

  • 3. Luminal and basolateral mechanisms involved in the renal tubular uptake of inorganic mercury.
    Zalups RK, Minor KH.
    J Toxicol Environ Health; 1995 Sep 24; 46(1):73-100. PubMed ID: 7666495
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug 24; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 6. Basolateral uptake of mercuric conjugates of N-acetylcysteine and cysteine in the kidney involves the organic anion transport system.
    Zalups RK.
    J Toxicol Environ Health A; 1998 Sep 11; 55(1):13-29. PubMed ID: 9747601
    [Abstract] [Full Text] [Related]

  • 7. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
    Zalups RK.
    Toxicol Appl Pharmacol; 1995 Jan 11; 130(1):121-31. PubMed ID: 7839359
    [Abstract] [Full Text] [Related]

  • 8. Depletion of glutathione in the kidney and the renal disposition of administered inorganic mercury.
    Zalups RK, Lash LH.
    Drug Metab Dispos; 1997 Apr 11; 25(4):516-23. PubMed ID: 9107552
    [Abstract] [Full Text] [Related]

  • 9. Renal disposition of mercury in rats after intravenous injection of inorganic mercury and cysteine.
    Zalups RK, Barfuss DW.
    J Toxicol Environ Health; 1995 Apr 11; 44(4):401-13. PubMed ID: 7723073
    [Abstract] [Full Text] [Related]

  • 10. Accumulation and handling of inorganic mercury in the kidney after coadministration with glutathione.
    Zalups RK, Barfuss DW.
    J Toxicol Environ Health; 1995 Apr 11; 44(4):385-99. PubMed ID: 7723072
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Simultaneous coexposure to inorganic mercury and cadmium: a study of the renal and hepatic disposition of mercury and cadmium.
    Zalups RK, Barfuss DW.
    J Toxicol Environ Health A; 2002 Oct 11; 65(19):1471-90. PubMed ID: 12396877
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relationships between alterations in glutathione metabolism and the disposition of inorganic mercury in rats: effects of biliary ligation and chemically induced modulation of glutathione status.
    Zalups RK, Barfuss DW, Lash LH.
    Chem Biol Interact; 1999 Dec 15; 123(3):171-95. PubMed ID: 10654838
    [Abstract] [Full Text] [Related]

  • 15. Basolateral uptake of inorganic mercury in the kidney.
    Zalups RK.
    Toxicol Appl Pharmacol; 1998 Jul 15; 151(1):192-9. PubMed ID: 9705903
    [Abstract] [Full Text] [Related]

  • 16. Cystine alters the renal and hepatic disposition of inorganic mercury and plasma thiol status.
    Zalups RK, Lash LH.
    Toxicol Appl Pharmacol; 2006 Jul 01; 214(1):88-97. PubMed ID: 16466761
    [Abstract] [Full Text] [Related]

  • 17. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK.
    J Pharmacol Exp Ther; 1993 Nov 01; 267(2):791-800. PubMed ID: 8246154
    [Abstract] [Full Text] [Related]

  • 18. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Feb 01; 408():1-260. PubMed ID: 12621522
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P, Giudicelli MD, Neau B, Gronfier A, Firmin Y, Villax P, Saivin S, Houin G.
    Arzneimittelforschung; 1998 Apr 01; 48(4):371-8. PubMed ID: 9608879
    [Abstract] [Full Text] [Related]

  • 20. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK.
    Toxicol Appl Pharmacol; 1997 Apr 01; 143(2):366-79. PubMed ID: 9144453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.